Browse by Funder

Number of items: 16.

Papalazarou, V., Newman, A. C., Huerta-Uribe, A., Legrave, N. M., Falcone, M., Zhang, T., McGarry, L., Athineos, D., Shanks, E., Blyth, K. , Vousden, K. H. and Maddocks, O. D. K. (2024) Phenotypic profiling of solute carriers characterizes serine transport in cancer. [Data Collection]

Nászai, M., Bellec, K. , Yu, Y., Román-Fernández, Á., Sandilands, E., Johansson, J., Campbell, A., Norman, J. , Sansom, O. , Bryant, D. and Cordero, J. (2021) RAL GTPases mediate EGFR-driven intestinal stem cell hyperproliferation and tumourigenesis. [Data Collection]

Hanna, C. (2021) Cancer Clinical Trials: Identifying & Testing Approaches to Impact Evaluation. [Data Collection] (Unpublished)

Bilsland, A. , Boyd, S., Turnbull, A., Jenkinson, D., Roffey, J. and Keith, N. (2019) Theoretical model of complex between phosphoglycerate kinase 1 and DJ1. [Data Collection]

Paul, J. , Boyd, K. , Briggs, A. , Cassidy, J., Harkin, A. and Iveson, T. (2019) The 'Short Course Oncology Treatment' (SCOT) trial. [Data Collection]

Sumpton, D., Keith, N. and Bilsland, A. (2018) Identification of novel pyrazolopyrimidine compounds that modulate the shelterin complex and telomere length regulation via phosphoglycerate kinase 1 and stress sensor DJ1. [Data Collection]

Turnbull, A. P., Bilsland, A., Liu, Y., Sumpton, D., Stevenson, K., Cairney, C., Roffey, J., Jenkinson, D. and Keith, N. (2018) PGK1 in complex with CRT0063465 (3-[2-(4-bromophenyl)-5,7-dimethyl-pyrazolo[1,5-a]pyrimidin-6-yl]propanoic acid). [Data Collection]

Maddocks, O. , Athineos, D., Cheung, E. C., Lee, P., Zhang, T., van den Broek, N. J.F., Mackay, G., Labuschagne, C. F., Gay, D., Kruiswijk, F., Blagih, J., Vincent, D., Campbell, K., Ceteci, F., Sansom, O. , Blyth, K. and Vousden, K. (2018) Modulating the therapeutic response of tumours to dietary serine and glycine starvation. [Data Collection]

Keith, N. and Bilsland, A. (2017) Luciferase assay for modulation of the human telomerase RNA component promoter. [Data Collection]

Keith, N. and Bilsland, A. (2017) Confirmatory assay for modulation of the human telomerase reverse transcriptase promoter in HCT116 cells. [Data Collection]

Keith, N. and Bilsland, A. (2017) Confirmatory dose-response cell survival assay for modulators of telomere damage signalling. [Data Collection]

Cairney, C., Godwin, L., Bilsland, A., Burns, S., Stevenson, K., McGarry, L., Revie, J., Moore, J., Wiggans, C., Collinson, R., Mudd, C., Tsonou, E., Sadaie, M., Bennet, D., Narita, M., Torrance, C. and Keith, N. (2017) A ‘synthetic-sickness’ screen for senescence re-engagement targets in mutant cancer backgrounds. [Data Collection]

Keith, N. and Bilsland, A. (2017) Cell survival assay for modulators of telomere damage signalling. [Data Collection]

Keith, N. and Bilsland, A. (2017) Luciferase assay for modulation of the human telomerase reverse transcriptase promoter. [Data Collection]

Bilsland, A., Pugliese, A., Liu, Y., Revie, J., Burns, S., McCormick, C., Cairney, C., Bower, J., Drysdale, M., Narita, M., Sadaie, M. and Keith, N. (2015) Identification of a selective G1-phase benzimidazolone inhibitor by a senescence-targeted virtual screen using artificial neural networks. [Data Collection]

Bilsland, A. (2013) Statespaceminer app. [Data Collection]

This list was generated on Fri Dec 6 17:26:13 2024 GMT.